A. M. Parfitt, M.R.C.P.
This content is PDF only. Please click on the PDF icon to access.
In view of dissatisfaction frequently expressed with current therapy of hypoparathyroidism, the incidence of hypercalcemia and its precipitating factors were studied in 21 patients with hypoparathyroidism followed for 1 to 6 years (mean, 3.5 years). Six patients—three postsurgical, two idiopathic, and one pseudo—were calcium-loaded (2.0 g/day) and calcium-deprived with cellulose phosphate, 15.0 g/day, and a low calcium diet; and 2 were phosphorus-loaded (2.0 g/day) and phosphorus-deprived. In all patients thyroid status was classified into grades I, II, and III according to the criteria of Canary and associates (Clin. Res. 16: 74, 1968). For this purpose, thyroid tissue was considered absent
Parfitt AM. Prevention of Hypercalcemia (Ca ↑) in Vitamin (D) Therapy of Hypoparathyroidism (HoPT).. Ann Intern Med. ;70:1064–1065. doi: 10.7326/0003-4819-70-5-1064_2
Download citation file:
Published: Ann Intern Med. 1969;70(5):1064-1065.
Endocrine and Metabolism, Fluid and Electrolyte Disorders, Nephrology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use